"While we are disappointed by the conduct of the past that led to this investigation, we strongly believe that settling this matter now is in the best interest of all of Ranbaxy's stakeholders," said Arun Sawhney, chief executive and managing director of Ranbaxy, in a statement.
ncG1vNJzZmivp6x7o67CZ5qopV%2Bjsri%2FjrCmq6SUYq60tcBmoKecmZZ6c36Ua2dybWM%3D